TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

Clinical trial NCT05729711 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05729711
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Bronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy)

Start date: 2023-04-04
Primary completion: 2029-11-16
Enrollment: 416

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.